Regulatory T cells (Tregs) play a critical role in maintaining immune tolerance and preventing autoimmune disease. Tregs express the transcription factor Foxp3, which acts as a master regulator of their differentiation and controls their capacity to suppress T cell responses. Tregs have an intrinsically anergic phenotype and do not produce IL-2 or proliferate upon stimulation ex vivo. Recent studies identified that Helios, a member of the Ikaros family of transcription factors, is expressed in Tregs. However, its specific function is not fully understood. In this study, we show that Helios regulates IL-2 production in Tregs by suppressing Il2 gene transcription. Loss of Helios in Tregs breaks their anergic phenotype and results in derepression of the Il2 locus, allowing Tregs to display increased baseline proliferation and to produce IL-2 following stimulation. Conversely, forced expression of Helios in CD4(+)Foxp3(-) T cells results in a loss of their normal ability to produce IL-2. Helios acts by binding to the Il2 promoter and inducing epigenetic modifications that include histone deacetylation. We also show that loss of Helios in Tregs results in decreased Foxp3 binding to the Il2 promoter, indicating that Helios promotes binding of Foxp3 to the Il2 promoter. Interestingly, the loss of Helios in Tregs also causes a decrease in suppressive capacity. Our results identify Helios as a key regulator of Il2 expression in Tregs, contributing to the maintenance of the anergic phenotype.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558938PMC
http://dx.doi.org/10.4049/jimmunol.1200792DOI Listing

Publication Analysis

Top Keywords

anergic phenotype
12
produce il-2
12
loss helios
12
helios tregs
12
il2 promoter
12
helios
10
tregs
10
il2 gene
8
regulatory cells
8
binding il2
8

Similar Publications

The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus.

Nat Rev Rheumatol

December 2024

AMPEL BioSolutions, Charlottesville, VA, USA.

Emerging evidence indicates that memory B cells are dysfunctional in systemic lupus erythematosus (SLE). They are hyporesponsive to signalling through the B cell receptor (BCR) but retain responsiveness to Toll-like receptor (TLR) and type I interferon signalling, as well as to T cell-mediated activation via CD40-CD154. Chronic exposure to immune complexes of ribonucleoprotein (RNP)-specific autoantibodies and TLR-engaging or BCR-engaging cargo is likely to contribute to this partially anergic phenotype.

View Article and Find Full Text PDF

Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations.

J Clin Immunol

August 2024

Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, No. 259, Wenhua 1st Rd., Guishan District, Taoyuan City, 33302, Taiwan.

Article Synopsis
  • Heterozygous STAT1 Gain-of-Function mutations are linked to chronic mucocutaneous candidiasis (CMC) and can lead to various immune disorders like autoimmune diseases and malignancies, with JAK inhibitors showing promise in treatment.
  • In a study of five Taiwanese patients, two new STAT1 GOF mutations were discovered, revealing clinical symptoms like CMC and autoimmunity, along with notable changes in immune cell types.
  • This research provides key insights into the immune dysregulation seen in STAT1 GOF patients and suggests that baricitinib is safe and effective for treatment, although further studies are needed to understand the underlying mechanisms driving these immune changes.
View Article and Find Full Text PDF

Background: Approximately 70% of individuals allergic to birch pollen (Bet v 1.01 [Bet]) develop a secondary food allergy (e.g.

View Article and Find Full Text PDF

Background: TG6050 was designed as an improved oncolytic vector, combining the intrinsic properties of vaccinia virus to selectively replicate in tumors with the tumor-restricted expression of recombinant immune effectors to modify the tumor immune phenotype. These properties might be of particular interest for "cold" tumors, either poorly infiltrated or infiltrated with anergic T cells.

Methods:  TG6050, an oncolytic vaccinia virus encodes single-chain human interleukin-12 (hIL-12) and full-length anti-cytotoxic T-lymphocyte-associated antigen-4 (@CTLA-4) monoclonal antibody.

View Article and Find Full Text PDF
Article Synopsis
  • Food allergies are serious medical conditions driven by harmful immune responses to certain foods, with current treatments often being long and only temporarily effective.
  • Researchers are investigating the use of nanoparticles that encapsulate allergens to directly suppress the harmful immune cells (Th2 cells) responsible for allergic reactions.
  • In mouse studies, administering these nanoparticles showed promising results by significantly reducing severe allergic reactions and reprogramming the immune response to be less reactive to allergens.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!